Harbinger Health
Total Raised
$190MInvestors Count
5Funding, Valuation & Revenue
2 Fundings
Harbinger Health has raised $190M over 2 rounds.
Harbinger Health's latest funding round was a Series B for $140M on September 28, 2023.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
9/28/2023 | Series B | $140M | Catalyst, Flagship Pioneering, M&G Investments, Partners Investment, Pictet Group, and Undisclosed Investors | 2 | ||
12/10/2021 | Series A |
Date | 9/28/2023 | 12/10/2021 |
|---|---|---|
Round | Series B | Series A |
Amount | $140M | |
Investors | Catalyst, Flagship Pioneering, M&G Investments, Partners Investment, Pictet Group, and Undisclosed Investors | |
Valuation | ||
Revenue | ||
Sources | 2 |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Harbinger Health Investors
5 Investors
Harbinger Health has 5 investors. Flagship Pioneering invested in Harbinger Health's Series B funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
12/10/2021 | 9/28/2023 | 2 Series A, Series B (2023) | Venture Capital | Massachusetts | ||
Investment Bank | Switzerland | |||||
Asset/Investment Management | United Kingdom | |||||
Venture Capital | South Korea | |||||
Private Equity | Israel |
First funding | 12/10/2021 | ||||
|---|---|---|---|---|---|
Last Funding | 9/28/2023 | ||||
Investor | |||||
Rounds | 2 Series A, Series B (2023) | ||||
Board Seats | |||||
Type | Venture Capital | Investment Bank | Asset/Investment Management | Venture Capital | Private Equity |
Location | Massachusetts | Switzerland | United Kingdom | South Korea | Israel |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Loading...